MedTrace Logo

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

NCT02940535 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-10-21

No results posted yet for this study

Summary

The management of the poor responder patients is very difficult. Currently, there is no any standard treatment for poor responder patients. The study is designed to test a modified GnRHa protocol for poor ovarian response, low dose GnRHa early luteal phase down regulation, compare with GnRHa ultra-short protocol. This is a randomized controlled trial.

Conditions

  • Subfertility, Female
  • Ovulation Disorder

Interventions

DRUG

Diphereline (Triptorelin embonate)

DRUG

Decapeptyl (Triptorelin)

DRUG

human menopausal gonadotropin

DRUG

human chorionic gonadotropin

Sponsors & Collaborators

  • Navy General Hospital, Beijing

    lead OTHER

Principal Investigators

  • Wei Shang, Dr · Navy General Hospital, Beijing

  • Yunhai Chuai, Dr · Navy General Hospital, Beijing

  • Mingming Shu, Dr · Navy General Hospital, Beijing

  • Ming Zhou, Dr · Navy General Hospital, Beijing

  • Huiming Han, Dr · Navy General Hospital, Beijing

  • Mengnan Chen, Dr · Navy General Hospital, Beijing

  • Lei Chen · Navy General Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02940535 on ClinicalTrials.gov